Data / Drug companies / Butalbital, acetaminophen, and caffeine
Butalbital, acetaminophen, and caffeine: 22 companies and 26 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Butalbital, acetaminophen, and caffeine is listed in the FDA National Drug Code Directory by 22 companies, with 26 products in commercial distribution. 26 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule; solution, and the newest product started marketing on January 8, 2026.
The request: Get every company that lists butalbital, acetaminophen, and caffeine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 22
- Products
- 26
- Generic (ANDA) products
- 26 (100.0%)
- Application numbers
- 6
- Controlled substance schedule
- Schedule III
- Routes
- Oral
- Brand names
- Butalbital, Acetaminophen, Caffeine, Butalbital, Acetaminophen and Caffeine, Fioricet
- openFDA record search
- api.fda.gov
Companies that list butalbital, acetaminophen, and caffeine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Actavis Pharma, Inc. | 2 | capsule; tablet | Generic drugs (ANDA) | July 29, 2013 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| Remedyrepack Inc. | 2 | tablet | Generic drugs (ANDA) | March 14, 2025 |
| A-S Medication Solutions | 1 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| Actavis Pharma, Inc. | 1 | capsule | Generic drugs (ANDA) | July 29, 2013 |
| Advanced Rx of Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | January 8, 2026 |
| Asclemed USA, Inc. | 1 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| AvKARE | 1 | capsule | Generic drugs (ANDA) | November 24, 2014 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | August 11, 2022 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| Cardinal Health 107, LLC | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| Genus Lifesciences | 1 | solution | Generic drugs (ANDA) | July 1, 2025 |
| Hawaii Repack, Inc. | 1 | tablet | Generic drugs (ANDA) | March 5, 2019 |
| LGM Pharma Solutions, LLC | 1 | tablet | Generic drugs (ANDA) | November 1, 2018 |
| Lannett Company, Inc. | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | February 11, 2022 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | September 13, 2012 |
| Sun Pharmaceutical Industries, Inc. | 1 | capsule | Generic drugs (ANDA) | July 1, 2020 |
| Westminster Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | March 5, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 21 | 80.8% |
| Capsule | 4 | 15.4% |
| Solution | 1 | 3.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 26 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Barbiturate | 26 |
| Central Nervous System Stimulant | 26 |
| Methylxanthine | 26 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.